Searchable abstracts of presentations at key conferences in endocrinology

ea0093oc15 | Oral communication 3: Adrenal Tumors and Neuroendocrine Tumors | EYES2023

Targeting the ferroptosis-macrophage crosstalk in adrenocortical carcinoma

Triebig Alexandra , Weigand Isabel , Atici Sena , Angeli Jose Pedro Friedmann , Kroisz Matthias

Background: Ferroptosis is an emerging form of regulated necrotic cell death characterized by excessive lipid peroxidation. Adrenocortical carcinoma (ACC) cells have been shown to be highly susceptible to ferroptosis caused by active steroid hormone synthesis. While therapeutic activation of ferroptosis has been proposed as a novel treatment strategy, its impact on the tumor immune microenvironment (TIME) remains elusive. Macrophages are an important TIME component and modulat...

ea0099p505 | Endocrine-Related Cancer | ECE2024

Growth differentiation factor 15 (GDF-15) is induced by mitotane in adrenocortical carcinoma and associated with poor prognosis and impaired responsiveness to immunotherapy

Weigand Isabel , Triebig Alexandra , Tanja Maier , Anderlik Tanja , Remde Hanna , Landwehr Laura-Sophie , Kimpel Otilia , Reuter Miriam , Schreiner Jochen , Wedekink Florian , Hoster Eva , Schwarzlmueller Paul , Reincke Martin , Wischhusen Jorg , Fassnacht Martin , Matthias Kroiss

Background: Treatment of adrenocortical carcinoma (ACC) is unsatisfactory in advanced stages. Oral mitotane remains a mainstay of treatment. Response rates of ACC to immune checkpoint inhibition (ICI) are disappointing and markers of response have not been identified. Tumoural infiltration with cells of the adaptive immune system is sparse in ACC tissue. Growth/differentiation factor 15 (GDF-15) is a cytokine that has been described to impair tumoral immune infiltration and is...